Fero Industries, Inc.
17 Reeves Crescent
17 Reeves Crescent
Alberta
T4P 2Z4
Canada
Tel: 403-827-7936
18 articles about Fero Industries, Inc.
-
Fero Industries, Inc. Changes Name to PharmaRoth Labs, Inc.
3/26/2013
-
Fero Industries, Inc. Issues Corporate Update
12/6/2012
-
Fero Industries, Inc. Announces Corporate Restructuring
7/13/2012
-
Fero Industries, Inc. Signs New Distribution Agreement to Expand Sucanon(R) Presence in the Middle East
12/22/2011
-
Fero Industries, Inc. to Expand Sucanon(R) Distribution through Government Institutions in Mexico
9/27/2011
-
Fero Industries, Inc. Appoints Lopez as President
9/1/2011
-
Fero Industries, Inc. Increases SucanonĀ® Promotion in Mexico with Physician Distributed Sample Packages
7/27/2011
-
Fero Industries, Inc. Expands SucanonĀ® Distribution in Mexico
7/13/2011
-
Fero Industries, Inc. Successfully Completes SucanonĀ® Type-2 Diabetes Human Clinical Trials in the Middle East
6/1/2011
-
Fero Industries, Inc. Announces Third Quarter Results and Initial Revenue From Sucanon(R) Sales in Mexico
5/19/2011
-
Fero Industries, Inc. Appoints Lopez as Chief Operating Officer
4/12/2011
-
Fero Industries, Inc. Makes Third Commercial Shipment of Sucanon(R) to Merck & Co., Inc.
3/31/2011
-
Fero Industries, Inc. Announces Commercial Launch of Sucanon(R) in Mexico
3/16/2011
-
Fero Industries, Inc. Release: Sucanon(R) Type-2 Diabetes Clinical Trials Reach Final Stage in Middle East
2/16/2011
-
Fero Industries, Inc. Selects Dr. Linda Allison to Head Strategic Advisory Committee
11/10/2010
-
Fero Industries, Inc. Appoints Lopez to Board of Directors
9/7/2010
-
Fero Industries, Inc. Discloses Growth Through Acquisition Strategy
12/9/2009
-
Fero Industries, Inc. to Acquire Pyro Pharmaceuticals, Inc.'s Enzyme Identification Methodology under Definitive Agreement
10/22/2009